Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Statin Use on Aldosterone Secretion
NCT02871687Phase 1Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2016
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in hypertension (HTN) and cardiovascular disease (CVD) comparing Placebo, Simvastatin and Pravastatin (3 arms). Primary endpoint: Serum aldosterone following angiotensin II infusion at 3 months. Started Apr 2016; status: completed.
02
Drugs
simvastatinpravastatin
03
Conditions
hypertension (HTN)cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02871687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02871687.